For
Figures 1B,
6A and
6F, the working stock of each mutant, T2 cells, were thawed and diluted 1:100 into fresh C+Y medium, or C+Y medium with doxycycline at different final concentrations, or with different concentrations of
S-(5’-Adenosyl)-L-methionine (A7007, Sigma Aldrich), as the initial cell culture. For
Figure 6D, the T2 cells were thawed and diluted 1:100 into fresh Blood Like Medium (BLM) without nucleobases solution, or supplemented with individual nucleobases component (adenine, adenosine, guanine, uracil, uridine and xanthine), or with all the components (Aprianto et al., 2018 (
link)). Then 300 μl of the initial culture was aliquoted into each well of 96-well plates with 3 replicates. Cell density were monitored by measuring OD595 every 10 minutes with a Tecan
Spark microtiter plate reader at 37°C. Luciferase assay (
Figure 1B) was performed as previously described (Liu et al., 2017 (
link)). Luciferin (D-Luciferin sodium salt, SYNCHEM OHG) was added into C+Y medium at final concentration of 450 μg/ml as substrate of the luciferase. Luminescence signals were measured every 10 minutes with a Tecan Spark microtiter plate. Growth and luciferase activity curves were plotted with Prism 8 as described previously (Sorg and Veening, 2015 (
link)).
Liu X., Kimmey J.M., Matarazzo L., de Bakker V., Maele L.V., Sirard J.C., Nizet V, & Veening J.W. (2020). Exploration of bacterial bottlenecks and Streptococcus pneumoniae pathogenesis by CRISPRi-seq. Cell host & microbe, 29(1), 107-120.e6.